Accelerate ID/AST System and ID/AST Blood Culture Acheives CE Mark
Accelerate Diagnostics, Inc., have announced its declaration of conformity to the European In Vitro Diagnostic Directive 98/79 EC and CE Mark of the Accelerate ID/AST System and ID/AST Blood Culture Assay for in vitro diagnostic use.
The Accelerate ID/AST System is a diagnostic platform providing rapid identification and antimicrobial susceptibility testing of serious infections.
In addition, the company initiated enrollment at 8 clinical trial sites for its preclinical study. Upon successful completion the FDA registration trial will begin. Given the aforementioned progress, the company maintains its expectation that it will launch an FDA cleared product in the United States in the first half of 2016.
How does it work? - http://acceleratediagnostics.com/our-science//
Tags: Antibiotic Sensitivity, Blood Culture, Identification, Antibiotic Resistance
Date Published: July 7, 2015
Source article link: Accelerate Diagnostics, Inc. » company contact details
12th Annual PDA Global Conference on Pharmaceutical Microbiology
Hygiena Expands Testing Portfolio to Cover Entire Contamination Detection Spectrum
First Automated Phenotypic Test for Carbapenemase Producing Organisms
Bruker Acquires MERLIN Adding Speciality AST and ART